Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Plant Physiology and Biochemistry : PPB
|
September 24, 2015
Identification and functional analysis of the autofluorescent substance in Limonium bicolor salt glands
Yunquan Deng, Zhongtao Feng, Fang Yuan, et al.
International Journal of Clinical and Experimental Medicine
|
November 10, 2015
Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient
Ying Li, Shanshan Suo, Liping Mao, et al.
Ejhaem
|
January 26, 2026
Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome Patient
Liya Ma, Yaojia Shen, Jie Chang, et al.
International Journal of Clinical and Experimental Pathology
|
January 18, 2020
Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma
Jie Jin, Lihong Cao, Lijun Wang, et al.
Leukemia Research
|
September 16, 2016
Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia
Yinjun Lou, Shanshan Suo, Hongyan Tong, et al.
Annals of Hematology
|
January 11, 2014
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
Yinjun Lou, Shanshan Suo, Yin Tong, et al.
BMC Medical Research Methodology
|
January 4, 2026
Cluster minimal sufficient balance (CMSB): an efficient covariate balancing randomization method for cluster randomized trials
Jiaxin Cai, Shanshan Suo, Valirie Ndip, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Efficacy of HAA regimen in the treatment of 64 patients with refractory/relapsed acute myeloid leukemia]
Cuihua Fan, Wenjuan Yu, Wenyuan Mai, et al.
Leukemia & Lymphoma
|
September 27, 2014
Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia
Jie Jin, Jian Chen, Shanshan Suo, et al.
Oncotarget
|
April 29, 2017
Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells
Jian Chen, Qitian Mu, Xia Li, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Plant Physiology and Biochemistry : PPB
|
September 24, 2015
Identification and functional analysis of the autofluorescent substance in Limonium bicolor salt glands
Yunquan Deng, Zhongtao Feng, Fang Yuan, et al.
International Journal of Clinical and Experimental Medicine
|
November 10, 2015
Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient
Ying Li, Shanshan Suo, Liping Mao, et al.
Ejhaem
|
January 26, 2026
Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome Patient
Liya Ma, Yaojia Shen, Jie Chang, et al.
International Journal of Clinical and Experimental Pathology
|
January 18, 2020
Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma
Jie Jin, Lihong Cao, Lijun Wang, et al.
Leukemia Research
|
September 16, 2016
Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia
Yinjun Lou, Shanshan Suo, Hongyan Tong, et al.
Annals of Hematology
|
January 11, 2014
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
Yinjun Lou, Shanshan Suo, Yin Tong, et al.
BMC Medical Research Methodology
|
January 4, 2026
Cluster minimal sufficient balance (CMSB): an efficient covariate balancing randomization method for cluster randomized trials
Jiaxin Cai, Shanshan Suo, Valirie Ndip, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 26, 2016
[Efficacy of HAA regimen in the treatment of 64 patients with refractory/relapsed acute myeloid leukemia]
Cuihua Fan, Wenjuan Yu, Wenyuan Mai, et al.
Leukemia & Lymphoma
|
September 27, 2014
Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia
Jie Jin, Jian Chen, Shanshan Suo, et al.
Oncotarget
|
April 29, 2017
Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells
Jian Chen, Qitian Mu, Xia Li, et al.
Page
of 3